Literature DB >> 17191243

Serial triple quantum sodium MRI during non-human primate focal brain ischemia.

G LaVerde1, E Nemoto, C A Jungreis, C Tanase, F E Boada.   

Abstract

Triple quantum (TQ) sodium MRI techniques with clinically acceptable 18-min data acquisition times were demonstrated in vivo in a nonhuman primate model of focal brain ischemia. Focal brain ischemia was induced in four animals using embolization coils to occlude the posterior cerebral artery, and a balloon catheter to occlude the middle cerebral artery. A statistically significant increase (P < 0.001) in the TQ sodium MRI signal intensity in the ischemic hemisphere relative to the contralateral hemisphere was seen at all time points in all four animals. This increased TQ sodium MRI signal intensity was demonstrated as early as 0.6 hr after the onset of ischemia. The TQ sodium MRI hyperintensity corresponded to the anatomical location of the ischemic cortex, as indicated by the registration of the TQ imaging data with anatomical proton MRI data. The results demonstrate that early after the onset of ischemia, there was an increase in the TQ signal intensity in the ischemic hemisphere, and a negligible change in the single quantum (SQ) signal intensity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17191243     DOI: 10.1002/mrm.21087

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  11 in total

1.  B₀ inhomogeneity-insensitive triple-quantum-filtered sodium imaging using a 12-step phase-cycling scheme.

Authors:  Lazar Fleysher; Niels Oesingmann; Matilde Inglese
Journal:  NMR Biomed       Date:  2010-12       Impact factor: 4.044

2.  Editorial.

Authors:  Weili Lin; William J Powers
Journal:  Transl Stroke Res       Date:  2012-04-17       Impact factor: 6.829

3.  23Na multiple quantum filtered NMR characterisation of Na+ binding and dynamics in animal cells: a comparative study and effect of Na+/Li + competition.

Authors:  Carla P Fonseca; Luís L Fonseca; Liliana P Montezinho; Paula M Alves; Helena Santos; M Margarida C A Castro; Carlos F G C Geraldes
Journal:  Eur Biophys J       Date:  2013-04-06       Impact factor: 1.733

Review 4.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

5.  Sodium-23 magnetic resonance imaging has potential for improving penumbra detection but not for estimating stroke onset time.

Authors:  Friedrich Wetterling; Lindsay Gallagher; Jim Mullin; William M Holmes; Chris McCabe; I Mhairi Macrae; Andrew J Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-22       Impact factor: 6.200

6.  Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

Authors:  Fernando E Boada; Yongxian Qian; Edwin Nemoto; Tudor Jovin; Charles Jungreis; S C Jones; Jonathan Weimer; Vincent Lee
Journal:  Transl Stroke Res       Date:  2012-05-04       Impact factor: 6.829

7.  Multimodal MRI of nonhuman primate stroke.

Authors:  Hsiao-Ying Wey; Timothy Q Duong
Journal:  Transl Stroke Res       Date:  2012-02-04       Impact factor: 6.829

8.  Sodium long-component T(2)(*) mapping in human brain at 7 Tesla.

Authors:  Lazar Fleysher; Niels Oesingmann; Bernd Stoeckel; Robert I Grossman; Matilde Inglese
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

9.  Elevated cerebrospinal fluid sodium in hypertensive human subjects with a family history of Alzheimer's disease.

Authors:  Lucas A C Souza; Fatima Trebak; Veena Kumar; Ryousuke Satou; Patrick G Kehoe; Wei Yang; Whitney Wharton; Yumei Feng Earley
Journal:  Physiol Genomics       Date:  2020-01-21       Impact factor: 3.107

10.  MAP2 immunostaining in thick sections for early ischemic stroke infarct volume in non-human primate brain.

Authors:  Alexander Kharlamov; George C LaVerde; Edwin M Nemoto; Charles A Jungreis; Victor E Yushmanov; Stephen C Jones; Fernando E Boada
Journal:  J Neurosci Methods       Date:  2009-06-21       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.